Contact
searchSearch
HMP Global
Login

July/August and September/October 2026

Editorial
An Expanded Issue, A Continued Commitment to Advancing Clinical Pathways
10/20/2026
Grace Taylor, MS, MA
This expanded issue of the Journal of Clinical Pathways features articles highlighting advances in oncology care, a continued commitment to high-quality clinical pathways research, and promising momentum heading into 2027.
This expanded issue of the Journal of Clinical Pathways features articles highlighting advances in oncology care, a continued commitment to high-quality clinical pathways research, and promising momentum heading into 2027.
This expanded issue of the...
10/20/2026
Journal of Clinical Pathways
Original Research
Evaluating the Impact of EHR-Supported Tools and Workflows on Broad Panel Testing Rates for Patients With Metastatic Prostate Cancer in a Community Urology Practice
10/20/2026
Jeffrey Marotte, MD; Katie O'Brien, BS; Stacy McDonnel, BS; Urmi Bapat, MD; Joyce LaMori, MHS, MBA; Kristi Cohn, MHA; Phoebe Socha, BS; Ralph Jonathan Henderson, MD
This pilot study demonstrates how implementing an electronic health record (EHR)-supported, guideline-based care pathway can increase broad panel genetic testing rates among patients with metastatic prostate cancer in community oncology.
This pilot study demonstrates how implementing an electronic health record (EHR)-supported, guideline-based care pathway can increase broad panel genetic testing rates among patients with metastatic prostate cancer in community oncology.
This pilot study demonstrates...
10/20/2026
Journal of Clinical Pathways
From the Field
The Urology Prostate Cancer Note: A Tool to Enhance the Use of the Prostate Cancer Clinical Pathways
10/19/2026
Sarah Neveills, PhD, MS, RN; Michael Goodman, MD; Jeremy Shelton, MD, MSHS
This study examines how implementing a standardized urology clinical note within the US Department of Veterans Health system improved documentation of prostate cancer clinical pathways.
This study examines how implementing a standardized urology clinical note within the US Department of Veterans Health system improved documentation of prostate cancer clinical pathways.
This study examines how...
10/19/2026
Journal of Clinical Pathways
Transformative Business Trends
The Next Evolution of Employer Health Plans
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how artificial intelligence, real-time analytics, and adaptive clinical pathways could shape 2027 benefit planning and simplify prior authorization.
This column examines how...
10/16/2026
Journal of Clinical Pathways
Transformative Business Trends
Medical Appropriateness and the Economics of Clinical Pathways
10/16/2026
F. Randy Vogenberg, PhD, FASHP
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how clinical guidelines and pathways have evolved to support medical appropriateness, balance financial responsibility, and address growing challenges in health care access and affordability.
This column explores how...
10/16/2026
Journal of Clinical Pathways
Pharma Insights
Preparing for Oncology Pathway Placement Before and After Drug Launch
10/15/2026
Gordon Kuntz
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how pharmaceutical manufacturers can incorporate clinical pathway strategies into oncology drug launch planning to improve treatment access and support preferred pathway placement.
This column explores how...
10/15/2026
Journal of Clinical Pathways
COA Viewpoint
What Survival Outcomes Reveal: New Evidence on Outcomes in Community Oncology
10/15/2026
Nicolas Ferreyros
This column highlights new real-world evidence linking independent community oncology care to favorable survival outcomes, emphasizing the importance of measuring quality and value beyond treatment costs.
This column highlights new real-world evidence linking independent community oncology care to favorable survival outcomes, emphasizing the importance of measuring quality and value beyond treatment costs.
This column highlights new...
10/15/2026
Journal of Clinical Pathways

Special Reports

Special Report
Advancing a Standardized Economic Framework to Power Oncology Pathways: Methods and Model Development From Phase II of the Predictable Cost of Care Working Group
04/23/2026
Edward Arrowsmith, MD; Alan J. Balch, PhD, MSc; Vishnukamal Golla, MD, MPH; Andrew Hertler, MD, FACP; David Jackman, MD; Olaf Lodbrok, MS, MBA; Lalan Wilfong, MD; Gordon Kuntz; Carole Tremonti, RN, MBA
As cancer therapies expand and costs rise, oncology pathway developers need consistent, transparent methods to compare treatment options beyond drug acquisition costs. Building on Phase I’s consensus on relevant cost domains, the Phase II PCC...
As cancer therapies expand and costs rise, oncology pathway developers need consistent, transparent methods to compare treatment options beyond drug acquisition costs. Building on Phase I’s consensus on relevant cost domains, the Phase II PCC...
As cancer therapies expand and...
04/23/2026
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

October 2026 Volume 12 Issue 4-5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use